Insider Transactions in Q2 2021 at Celanese Corp (CE)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 17
2021
|
Scott A Richardson EVP & COO |
SELL
Open market or private sale
|
Direct |
6,500
-15.24%
|
$1,079,000
$166.65 P/Share
|
May 03
2021
|
Vanessa Dupuis SVP, HR (CHRO) |
SELL
Open market or private sale
|
Direct |
1,204
-22.08%
|
$190,232
$158.5 P/Share
|
May 01
2021
|
Lori Ryerkerk Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,812
-8.51%
|
$594,672
$156.86 P/Share
|
Apr 30
2021
|
Deborah J. Kissire Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
754
-41.22%
|
-
|
Apr 30
2021
|
William M Brown Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,849
-63.17%
|
-
|
Apr 30
2021
|
Kim K.W. Rucker Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,849
-64.2%
|
-
|
Apr 27
2021
|
Jean S Blackwell Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+10.63%
|
-
|
Apr 27
2021
|
William M Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+24.99%
|
-
|
Apr 27
2021
|
Edward G Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+8.21%
|
-
|
Apr 27
2021
|
Kathryn Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+8.53%
|
-
|
Apr 27
2021
|
David F Hoffmeister Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+2.02%
|
-
|
Apr 27
2021
|
Jay V Ihlenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+10.31%
|
-
|
Apr 27
2021
|
Deborah J. Kissire Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+34.77%
|
-
|
Apr 27
2021
|
Kim K.W. Rucker Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+25.29%
|
-
|
Apr 27
2021
|
John K Wulff Director |
BUY
Grant, award, or other acquisition
|
Direct |
975
+7.4%
|
-
|
Apr 12
2021
|
John K Wulff Director |
SELL
Open market or private sale
|
Direct |
6,000
-18.77%
|
$924,000
$154.01 P/Share
|